the oil will, in someone else's reserves. But I'll bet management makes money on the bankruptcy and the sale.
lol, they've been saying that for 10 years. They are worthless and most likely taking bribes and making money on their own failure to act. There isn't a stock on the biotech board that isn't manipulated daily and doesn't have multiple complaints filed. Not a one.
to take it private he'd have to pony up, no one would float him. If he won't spend 2 bucks to buy a share on the open market he won't spend any multiple to take it private. Listen to him on the CC. Even he doesn't believe in the future. Hasn't done one thing since belviq was approved. He lost a year of market dominance by goofing around with the DEA and now is behind sales to a black box poison that happened on the scene 15 months after approval of lorcaserin. He's lost, except when he goes to deposit his check. Approval right now in Israel, Mexico and Brazil would bump this up to $4, maybe. the BOD and him will surely see class action sooner than later. What better way to spend millions than defending the indefensible. Except of course for the bonuses I'm certain will be forthcoming.
that's ok. It will not lose absolute value nor strategic value and will continue to pay a nice dividend and future share price will rise, not tomorrow but soon enough. A buy out is not offered so the buying company can lose money or even break even, they know the future value to them and want it for less than it is. This management knows what it's doing, on this at least.. I think no deal is better than a bad deal. Now where did I hear that before?
why is it that markets look forward for everything but buy outs.?
it’s got billions in capital investment projects coming online, the value of which is not yet reflected in the stock price.
I concur and posted this some time ago in another thread: " it's estimated 11500 new spinal cord injuries per year. approximately 21.6% are complete paraplegics. That's about 2500/year or 207/month on average in 50 states that are candidates. Seasonality plays a part as does location. Add into that admission criteria and subtract those who opt not to participate and the pool is more limited than you'd think even though the number afflicted greater than anyone wants. We're doing fine". 11500 was the middle of the estimated range, may be less or more as you have posted. TBIs are not classified as spinal cord so are not included in this number.
it's managements way of rewarding their HF friends. Play the game with them. this is a trading stock now so trade around a core position to lower your CA.
it is transformative. He's transformed a solid biotech into a personal cash cow that he will bankrupt in due time if he isn't replaced. It's already 2 years too late and the point of no return looms closer. If it gets much lower it will be taken out with a 50% premium and all early investors who kept this thing afloat will take a loss even with a buy out. except jack, and perhaps the ball girl.
ummm, I guess completion is good news. but reported results is what will move this higher . temporarily. If they're good results.
so when can shareholders expect to get their share of this fine with interest? Oh, neber you say. SEC are bigger criminals than the houses they fine.
a distinct possibility. Paying more for an experiment doesn't make much sense especially if you're an ACA insured. Vehicle accidents are a major cause of these injuries. I'm not sure how much say they have in procedure cost but are capped in total dollars depending on elected coverage of the insured.